Stroke in patients with left ventricular assist device (LVAD): who is at risk?-a retrospective observational study at a tertiary care center.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Frontiers in Cardiovascular Medicine Pub Date : 2025-09-09 eCollection Date: 2025-01-01 DOI:10.3389/fcvm.2025.1591208
Yasemin Akalan, Hans Worthmann, Dominik Berliner, Juliane Hupe, Gerrit M Grosse, Omar Abu-Fares, Kim K Ravenberg, Karin Weissenborn, Arjang Ruhparwar, Steven R Talbot, Johann Bauersachs, Jan D Schmitto, Jasmin S Hanke, Maria M Gabriel
{"title":"Stroke in patients with left ventricular assist device (LVAD): who is at risk?-a retrospective observational study at a tertiary care center.","authors":"Yasemin Akalan, Hans Worthmann, Dominik Berliner, Juliane Hupe, Gerrit M Grosse, Omar Abu-Fares, Kim K Ravenberg, Karin Weissenborn, Arjang Ruhparwar, Steven R Talbot, Johann Bauersachs, Jan D Schmitto, Jasmin S Hanke, Maria M Gabriel","doi":"10.3389/fcvm.2025.1591208","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Stroke is a severe complication in patients with left ventricular assist devices (LVAD), significantly affecting quality of life and potentially leading to death. This study aimed to illustrate the clinical features, outcomes, and risk factors associated with stroke in LVAD patients, with the goal of identifying potential treatment targets.</p><p><strong>Methods: </strong>In a study of 249 consecutive patients who underwent LVAD implantation, detailed evaluations were conducted regarding clinical characteristics, perioperative management, cardiovascular risk factors, comorbidities, and brain imaging. The etiology, treatment, and outcomes were subsequently assessed in individuals who encountered a stroke.</p><p><strong>Results: </strong>Eighty-three cerebrovascular events (CVE) occurred in 54/249 patients during a median study period of 2.2 years (0.4-3.5) with 53 ischemic events and 22 intracranial hemorrhages (ICH). Early peri- or postoperatively CVE in context to the LVAD implantation were identified in 31 patients. Competing risks regression analysis revealed that postoperative dialysis was associated with higher risk for CVE, considering death as competing risk event (HR 3.617; 95%-CI: 1.78-7.35; <i>p</i> ≤ 0.001). Modified Rankin Scale at outpatient visit did not differ in early CVE [3 (IQR 2-5) vs. 3 (IQR2-4), <i>p</i> = 0.146]. Late CVE frequently occurred during hospitalization for sepsis or in cardiac rehabilitation [<i>n</i> = 16/41 events (39%)]. Competing risk analysis treating death and heart transplantation as competitors identified history of stroke as associated factor [HR 3.564; 95%-CI (1.67-7.169); <i>p</i> = 0.001]. Mortality was not associated with CVE [with <i>n</i> = 27/54 (50%) vs. without CVE 94/195 (48.2%) <i>p</i> = 0.183].</p><p><strong>Conclusion: </strong>Patients who require postoperative dialysis face a heightened risk for early cerebrovascular events (CVE) during and after LVAD implantation. Additionally, a history of stroke and complicated clinical courses should increase awareness regarding the potential for impending CVE in the long term.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1591208"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454346/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1591208","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Stroke is a severe complication in patients with left ventricular assist devices (LVAD), significantly affecting quality of life and potentially leading to death. This study aimed to illustrate the clinical features, outcomes, and risk factors associated with stroke in LVAD patients, with the goal of identifying potential treatment targets.

Methods: In a study of 249 consecutive patients who underwent LVAD implantation, detailed evaluations were conducted regarding clinical characteristics, perioperative management, cardiovascular risk factors, comorbidities, and brain imaging. The etiology, treatment, and outcomes were subsequently assessed in individuals who encountered a stroke.

Results: Eighty-three cerebrovascular events (CVE) occurred in 54/249 patients during a median study period of 2.2 years (0.4-3.5) with 53 ischemic events and 22 intracranial hemorrhages (ICH). Early peri- or postoperatively CVE in context to the LVAD implantation were identified in 31 patients. Competing risks regression analysis revealed that postoperative dialysis was associated with higher risk for CVE, considering death as competing risk event (HR 3.617; 95%-CI: 1.78-7.35; p ≤ 0.001). Modified Rankin Scale at outpatient visit did not differ in early CVE [3 (IQR 2-5) vs. 3 (IQR2-4), p = 0.146]. Late CVE frequently occurred during hospitalization for sepsis or in cardiac rehabilitation [n = 16/41 events (39%)]. Competing risk analysis treating death and heart transplantation as competitors identified history of stroke as associated factor [HR 3.564; 95%-CI (1.67-7.169); p = 0.001]. Mortality was not associated with CVE [with n = 27/54 (50%) vs. without CVE 94/195 (48.2%) p = 0.183].

Conclusion: Patients who require postoperative dialysis face a heightened risk for early cerebrovascular events (CVE) during and after LVAD implantation. Additionally, a history of stroke and complicated clinical courses should increase awareness regarding the potential for impending CVE in the long term.

Abstract Image

Abstract Image

Abstract Image

左心室辅助装置(LVAD)患者卒中:谁有危险?-在三级保健中心进行回顾性观察研究。
目的:卒中是左心室辅助装置(LVAD)患者的严重并发症,显著影响生活质量并可能导致死亡。本研究旨在阐明LVAD患者与卒中相关的临床特征、结局和危险因素,以确定潜在的治疗靶点。方法:对249例连续行LVAD植入患者的临床特征、围手术期处理、心血管危险因素、合并症和脑成像进行详细评估。随后对中风患者的病因、治疗和结果进行了评估。结果:在平均2.2年(0.4-3.5年)的研究期间,249例患者中有54例发生了83例脑血管事件(CVE),其中53例为缺血性事件,22例为颅内出血(ICH)。在31例患者中发现了与LVAD植入相关的早期围手术期或术后CVE。竞争风险回归分析显示,考虑到死亡是竞争风险事件,术后透析与CVE的高风险相关(HR 3.617; 95% ci: 1.78-7.35; p≤0.001)。改良Rankin量表在早期CVE患者门诊就诊时无差异[3 (IQR 2-5) vs. 3 (IQR2-4), p = 0.146]。晚期CVE多发生在败血症住院或心脏康复期间[n = 16/41例(39%)]。将死亡和心脏移植作为竞争对手的竞争风险分析确定卒中史为相关因素[HR 3.564;95%可信区间(1.67 - -7.169);p = 0.001]。死亡率与CVE无关[n = 27/54 (50%) vs.无CVE 94/195 (48.2%) p = 0.183]。结论:术后需要透析的患者在LVAD植入期间和之后面临更高的早期脑血管事件(CVE)风险。此外,卒中史和复杂的临床病程应提高对潜在的慢性脑血管病的认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信